Dean & Company has an established, highly successful track record in generating actionable and quantifiable results for our clients in the Life Sciences. These include a number of the largest global companies as well as emerging leaders in the Pharmaceuticals, Biotechnology, Vaccines, and Medical Devices & Technology industries.
The hallmark of our work in life sciences, as in other industries, is our ability to deliver analysis-driven solutions to complex business problems and develop practical, action-oriented recommendations with impact on the bottom-line. Learn more about the Dean Value Proposition >>
Our Capabilities
Dean & Company has assisted life sciences clients on a wide range of issues, including high-level strategic thinking, M&A strategy and due diligence, and key functional initiatives such as customer targeting and channel optimization. Learn more >>
Representative Client Engagements
Dean & Company has helped top global biopharma companies, specialty pharma companies, emerging biotechs, medical device companies, public sector institutions, and private equity investors analyze high leverage issues and develop concrete and actionable business strategies. Representative client engagements include:
Market Opportunity Assessment:
- Dean & Company was engaged by Diffusion Pharmaceuticals, a private clinical-stage pharmaceutical company, to conduct a market opportunity assessment of two indications for its lead product candidate, trans sodium crocetinate (TSC) Learn more >>
Pipeline Drug Valuation:
- As part of a commercial assessment, Dean & Company conducted a full risk-adjusted valuation of a target pipeline drug, which was in Phase II/III trials for the treatment of advanced malignant melanoma, as well as a second indication Learn more >>
Market Planning and Pricing:
- A global plasma therapeutics company was seeking to increase uptake of its emphysema and alpha-1-antitrypsin deficiency (AATD) therapy product, and asked Dean & Company to look at opportunities to expand the product franchise Learn more >>
Private Equity Due Diligence:
- A private equity client asked Dean & Company to perform due diligence on a development-stage biotech investment target Learn more >>
